You have 9 free searches left this month | for more free features.

Condition

NASH - Nonalcoholic Steatohepatitis (2)

Diabetes Mellitus, Type 2 (1)

Diffuse Cutaneous Systemic Sclerosis (1)

Non-Alcoholic Steatohepatitis (NASH) (1)

Scleroderma, Diffuse (1)

Overall Status

Completed (2)

Recruiting (2)

Sign in for free

Phase

phase 2 (3)

phase 3 (1)

Sponsor

Inventiva Pharma (4)

Collaborator

Intervention

iva337 (4)

placebo (4)

empagliflozin (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

iva337

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non-Alcoholic Steatohepatitis (NASH) Trial in Worldwide (IVA337, Placebo)

Completed

Non-Alcoholic Steatohepatitis (NASH)

IVA337
Placebo

Madison, Alabama
+84 more

Mar 16, 2021

NASH - Nonalcoholic Steatohepatitis, Diabetes, Type 2 Trial in Worldwide (IVA337, Placebo, Empagliflozin)

Recruiting

NASH - Nonalcoholic Steatohepatitis
Diabetes Mellitus, Type 2

IVA337
+2 more

Homewood, Alabama
+40 more

Jan 23, 2023

NASH - Nonalcoholic Steatohepatitis Trial in Worldwide (IVA337, Placebo)

Recruiting

NASH - Nonalcoholic Steatohepatitis

IVA337
Placebo

Anniston, Alabama
+352 more

Jan 23, 2023

Scleroderma, Diffuse, Diffuse Cutaneous Systemic Sclerosis Trial in Worldwide (IVA337, Placebo)

Completed

Scleroderma, Diffuse
Diffuse Cutaneous Systemic Sclerosis

IVA337
Placebo

Pleven, Bulgaria
+48 more

Mar 1, 2019